2 results
Approved WMOCompleted
Primary Objective:To demonstrate that CHF 1535 twice daily is superior to Formoterol twice daily in terms of COPD exacerbations rate during 48 weeks of treatment and in terms of pulmonary function (change in pre-dose morning FEV1 from baseline to 12…
Approved WMOPending
The primary objective is to determine the survival rate after two and five years in fixed bearing Oxford lateral PKR with an uncemented femoral component and present patient reported outcome measures (PROMS), range of motion, radiographic findings…